MedPath

Investigation of comorbidity, treatment resistance, severity, functional disability, QOL for psychiatric disorders.

Not Applicable
Conditions
Depressive disorder, Persistent Depressive Disorder, Bipolar 1 disorder, Bipolar 2 Disorder, Panic Disorder, Agoraphobia, Social anxiety Disorder, Obsessive-Compulsive disorder, PTSD, Substance related disorder, Anorexia nervosa, Bulimia Nervosa, General anxiety disorder (DSM-5)
Registration Number
JPRN-UMIN000035197
Lead Sponsor
agoya City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who were diagnosed/ strongly suspected neurodevelopment disorders, schizophrenia spectrum and other psychotic disorders, neurocognitive disorders, manic episode, hypomanic episode, epilepsy or mental disorder due to medical condition by DSM-5 2) Patients who can't understand Japanese well. 3) Patients who had participated in this study. 4) Patients who were supposed to be hospitalized in 7 days. 5) Patients who their research doctor consider not suited.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
On admission Interpersonal sensitivity measure: IPSM Ten Item Personality Inventory: TIPI Confidant Parental Bonding Instrument: PBI BDI-2 EQ5D Sheehan Disability Scale; SDS After 28day-42day at admission BDI-2 EQ5D Sheehan Disability Scale: SDS Interpersonal Sensitivity Measure; IPSM
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath